Financials
- Market Capitalization 218.12 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.53
Rapporto prezzo/fatturato
8.08
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3471 | GLSI Greenwich LifeSciences, Inc. - Common stock | 14.98 USD | -15.70% | -9.60% | -1.12% | +46.86% | 219.88 M USD | ||
| 3475 | ADCT ADC Therapeutics SA Common Shares | 1.71 USD | -8.06% | +36.80% | +59.81% | -61.74% | 218.31 M USD | ||
| 3493 | STRO Sutro Biopharma, Inc. - Common Stock | 11.45 USD | -13.78% | -22.32% | -33.00% | -34.16% | 189.85 M USD | ||
| 3518 | RNAC Cartesian Therapeutics, Inc. - Common Stock | 6.69 USD | -4.29% | -5.51% | -18.32% | -26.97% | 202.41 M USD |